Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT.

Authors :: Polverelli N
Bonneville EF
de Wreede LC
Koster L
Kröger NM
Schroeder T
Peffault de Latour R
Passweg J
Sockel K
Broers AEC
Clark A
Dreger P
Blaise D
Yakoub-Agha I
Petersen SL
Finke J
Chevallier P
Helbig G
Rabitsch W
Sammassimo S
Arcaini L
Russo D
Drozd-Sokolowska J
Raj K
Robin M
Battipaglia G
Czerw T
Hernández-Boluda JC
McLornan DP
Source :: American journal of hematology [Am J Hematol] 2024 May; Vol. 99 (5), pp. 993-996. Date of Electronic Publication: 2024 Feb 22.
Publication Year :: 2024
Abstract: Investigating the evaluation of eligibility for transplant in myelofibrosis (MF): The role of HCT-CI and BMI. HCT-CI emerges as a key prognostic factor, while BMI shows limited impact. This study expands insights for better clinical decision-making in MF allo-HCT.<br /> (© 2024 Wiley Periodicals LLC.)

Subjects :: Humans
Body Mass Index
Retrospective Studies
Transplantation Conditioning
Primary Myelofibrosis therapy
Neoplasms
Hematopoietic Stem Cell Transplantation

Full Text Access

Tools